Xiangbei Welman Pharmaceutical Co., Ltd.
As of 18 November 2026, for the company name Xiangbei Welman Pharmaceutical Co., Ltd. as recorded, the chemical-drug catalogue lists 31 active records with this name as holder; 12 active API registrations list this name as first registered company.
Check drug filings and source records for this company-name string.
Listed by the company name as recorded in the source, without merging affiliated entities.
Page reference
These counts cover loaded acceptance records only. First-applicant and co-applicant counts are not added together. CDE data as of 2026/11/18.
Drug filings
55 acceptance records as first applicant, grouped into 19 source drug names. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Acceptance records are de-duplicated by acceptance number. Drug names are normalized only for width and whitespace; dosage forms and combinations remain separate. Application types are retained from the source. Expand a drug to inspect each record. Published drugs link to their drug pages; other names do not create new public drug pages.
Baloxavir Marboxil Tablets 2 records · Latest accepted 2026/06/04
Generic · 2
Piperacillin Sodium And Tazobactam Sodium For Injection 3 records · Latest accepted 2026/06/01
Supplement · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2601040 | Supplement | 2026/06/01 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2550126 | Supplement | 2025/02/26 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2550125 | Supplement | 2025/02/26 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Sildenafil Citrate Tablets 3 records · Latest accepted 2025/08/28
Generic · 3
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2503156 | Generic | 2025/08/28 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2503155 | Generic | 2025/08/28 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2500190 | Generic | 2025/01/09 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Levofloxacin Tablets 2 records · Latest accepted 2025/08/23
Supplement · 1Generic · 1
F-02-2-Na片 · No verified English name 1 records · Latest accepted 2025/06/18
New drug · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CXHL2500587 | New drug | 2025/06/18 | Xiangbei Welman Pharmaceutical Co., Ltd.; Guangzhou Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized; Guangdong Heng Qin Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
注射用头孢噻肟钠他唑巴坦钠 · No verified English name 5 records · Latest accepted 2025/02/19
Supplement · 3Generic · 2
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2500332 | Supplement | 2025/02/19 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2500331 | Supplement | 2025/02/19 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2402034 | Supplement | 2024/11/30 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200903 | Generic | 2022/06/16 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2200902 | Generic | 2022/06/16 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Dapoxetine Hydrochloride Tablets 2 records · Latest accepted 2024/08/30
Generic · 2
Cefoperazone Sodium and Sulbactam Sodium for Injection 8 records · Latest accepted 2024/08/09
Generic · 3Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402584 | Generic | 2024/08/09 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402583 | Generic | 2024/08/09 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2402582 | Generic | 2024/08/09 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450364 | Supplement | 2024/07/08 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450363 | Supplement | 2024/07/08 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450362 | Supplement | 2024/07/08 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450361 | Supplement | 2024/07/08 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450360 | Supplement | 2024/07/08 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Ceftazidime And Avibactam Sodium For Injection 1 records · Latest accepted 2024/08/02
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2402452 | Generic | 2024/08/02 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Cefotaxime Sodium For Injection 5 records · Latest accepted 2024/05/31
Supplement · 5
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2450311 | Supplement | 2024/05/31 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450310 | Supplement | 2024/05/31 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450309 | Supplement | 2024/05/31 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450308 | Supplement | 2024/05/31 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2450307 | Supplement | 2024/05/31 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Tadalafil Tablets 4 records · Latest accepted 2024/03/15
Generic · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2400852 | Generic | 2024/03/15 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2400851 | Generic | 2024/03/15 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2400850 | Generic | 2024/03/15 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHS2301655 | Generic | 2023/06/19 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Acetylcysteine Granules 2 records · Latest accepted 2024/02/21
Generic · 2
注射用头孢噻肟钠舒巴坦钠 · No verified English name 6 records · Latest accepted 2023/12/16
Supplement · 6
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302747 | Supplement | 2023/12/16 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302746 | Supplement | 2023/12/16 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302745 | Supplement | 2023/12/16 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302744 | Supplement | 2023/12/16 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2200183 | Supplement | 2022/01/21 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2200182 | Supplement | 2022/01/21 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
注射用头孢曲松钠舒巴坦钠 · No verified English name 4 records · Latest accepted 2023/12/12
Supplement · 4
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2302706 | Supplement | 2023/12/12 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302705 | Supplement | 2023/12/12 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2302704 | Supplement | 2023/12/12 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| CYHB2200177 | Supplement | 2022/01/21 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
莫达非尼胶囊 · No verified English name 2 records · Latest accepted 2023/09/02
Supplement · 2
Amoxicillin and Clavulanate Potassium Tablets 1 records · Latest accepted 2023/06/28
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2350504 | Supplement | 2023/06/28 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Sevelamer Carbonate Tablets 1 records · Latest accepted 2022/08/23
Generic · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHS2201351 | Generic | 2022/08/23 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
注射用哌拉西林钠舒巴坦钠 · No verified English name 2 records · Latest accepted 2022/01/21
Supplement · 2
注射用头孢哌酮钠他唑巴坦钠 · No verified English name 1 records · Latest accepted 2022/01/21
Supplement · 1
| Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|
| CYHB2200179 | Supplement | 2022/01/21 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Changes in the last 90 days
0 events from 2026/08/22 to 2026/11/19. CDE data as of 2026/11/18; NMPA data as of 2026/11/19.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
Last 90 days, ordered by fact date. Marketing approvals, trial registrations, supplements, notices and review changes are labelled separately. Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
- No matching records were found in the currently loaded source data; coverage dates are listed below.
Under review
4 acceptance numbers with this company as first applicant are currently listed as under review by CDE. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Baloxavir Marboxil Tablets | CYHS2601297 | Generic | 2026/06/04 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| Baloxavir Marboxil Tablets | CYHS2601296 | Generic | 2026/06/04 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Tablets | CYHS2503156 | Generic | 2025/08/28 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| Sildenafil Citrate Tablets | CYHS2503155 | Generic | 2025/08/28 | Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
Catalogue holder records
31 loaded active catalogue records whose holder name matches this source company name. Source data as of 2026/11/18. Manufacturer-only records are excluded.
| Drug | Marketing authorization holder | Manufacturer | Approval number | Approved | Catalogue category (source text) | View source |
|---|---|---|---|---|---|---|
| Piperacillin Sodium And Tazobactam Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20269222 | 2026/09/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Sildenafil Citrate Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20265155 | 2026/07/14 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20073599 | 2026/04/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Piperacillin Sodium And Tazobactam Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20073597 | 2026/04/10 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Ceftazidime And Avibactam Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20263191 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20263211 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20263212 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20263213 | 2026/01/27 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Dapoxetine Hydrochloride Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20256002 | 2025/11/18 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Sevelamer Carbonate Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20255915 | 2025/11/12 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20033962 | 2025/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20258169 | 2025/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20033961 | 2025/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20023687 | 2025/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefoperazone Sodium and Sulbactam Sodium for Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20013112 | 2025/08/25 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20034139 | 2025/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20258157 | 2025/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H43020388 | 2025/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H43020386 | 2025/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Cefotaxime Sodium For Injection | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20033894 | 2025/08/07 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tadalafil Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20254918 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20254916 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Acetylcysteine Granules | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20254217 | 2025/05/20 | Not stated by source | CDE ↗ |
| Acetylcysteine Granules | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20254218 | 2025/05/20 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Tadalafil Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20249149 | 2024/10/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amoxicillin and Clavulanate Potassium Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20030461 | 2024/08/09 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 莫达非尼胶囊 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20170014 | 2024/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| 莫达非尼胶囊 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20170013 | 2024/08/01 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Levofloxacin Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20234068 | 2023/08/29 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
| Amoxicillin and Clavulanate Potassium Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20051710 | 2021/08/20 | Drug that passed quality-and-efficacy consistency evaluation | CDE ↗ |
| Tadalafil Tablets | Xiangbei Welman Pharmaceutical Co., Ltd. | Xiangbei Welman Pharmaceutical Co., Ltd. | 国药准字H20254917 | 2025/07/22 | Generic approved under the new chemical-drug registration classification | CDE ↗ |
Only active catalogue records matching the source holder name are listed. A manufacturer role does not count as a holder record. The catalogue covers only part of the chemical-drug market; source categories do not establish complete market coverage or qualifications.
API registrations
12 loaded active API registrations whose first registered company matches this source company name. Source data as of 2026/11/18.
| Name | Company / applicant | Registration number | Status | Source update date | View source |
|---|---|---|---|---|---|
| 他唑巴坦钠 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20260000491 | I | 2026/07/01 | CDE ↗ |
| 右莰醇 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20260000240 | I | 2026/03/31 | CDE ↗ |
| 玛巴洛沙韦 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20260000150 | I | 2026/03/10 | CDE ↗ |
| 磷酸芦可替尼 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20260000039 | I | 2026/02/09 | CDE ↗ |
| 盐酸埃克替尼 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20250001237 | I | 2025/11/24 | CDE ↗ |
| 哌拉西林钠 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20250001050 | I | 2025/10/15 | CDE ↗ |
| 多司马酯 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20250000307 | I | 2025/04/07 | CDE ↗ |
| 艾普拉唑 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20240001539 | A | 2026/07/13 | CDE ↗ |
| 马来酸阿伐曲泊帕 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20230001084 | A | 2025/07/14 | CDE ↗ |
| 他达拉非 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20220001003 | A | 2026/04/14 | CDE ↗ |
| 丁苯酞 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20220000692 | A | 2024/12/27 | CDE ↗ |
| 莫达非尼 · No verified English name | Xiangbei Welman Pharmaceutical Co., Ltd. | Y20190008895 | A | 2025/06/28 | CDE ↗ |
Only loaded active API registrations not listed as cancelled are shown. A/I are source registration statuses. Records are listed by registration number and do not establish capacity or supply. The register does not identify the associated formulation.
Co-applicant records
11 acceptance records name this company after the first applicant. They are listed separately and are not included in first-applicant drug or filing counts. Source data as of 2026/11/18.
This source was last successfully updated at 2026/11/18; current coverage may be incomplete.
| Drug | Acceptance number | Application type | Accepted | Company / applicant | View source |
|---|---|---|---|---|---|
| Amoxicillin Sodium and Clavulanate Potassium for Injection | CYHS2601582 | Generic | 2026/07/03 | Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| F-02-2-Na片 · No verified English name | CXHL2500589 | New drug | 2025/06/18 | Guangdong Heng Qin Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.; Guangzhou Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| F-02-2-Na片 · No verified English name | CXHL2500588 | New drug | 2025/06/18 | Guangdong Heng Qin Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd.; Guangzhou Xin Chuang Yi Biopharmaceuticals Co., Ltd. romanized | CDE ↗ |
| Amoxicillin Sodium for Injection | CYHS2302386 | Generic | 2023/09/05 | Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| Amoxicillin Sodium for Injection | CYHS2302385 | Generic | 2023/09/05 | Guangzhou Ai Qi Xi Xin Yao Research Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用头孢曲松钠舒巴坦钠 · No verified English name | CYHB2102131 | Supplement | 2021/11/11 | Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用头孢噻肟钠舒巴坦钠 · No verified English name | CYHB2102130 | Supplement | 2021/11/11 | Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用头孢噻肟钠舒巴坦钠 · No verified English name | CYHB2102129 | Supplement | 2021/11/11 | Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用哌拉西林钠舒巴坦钠 · No verified English name | CYHB2102128 | Supplement | 2021/11/11 | Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用哌拉西林钠舒巴坦钠 · No verified English name | CYHB2102127 | Supplement | 2021/11/11 | Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
| 注射用头孢哌酮钠他唑巴坦钠 · No verified English name | CYHB2102126 | Supplement | 2021/11/11 | Hunan Wei Er Qiang Pharmaceutical Co., Ltd. romanized; Xiangbei Welman Pharmaceutical Co., Ltd. | CDE ↗ |
How current is each source?
- CDE acceptances and review
- Last successful update: 2026/11/18 · Current coverage may be incomplete
- Chemical-drug catalogue
- Last successful update: 2026/11/18
- API registrations
- Last successful update: 2026/11/18
- NMPA drug delivery notices
- Last successful update: 2026/11/19
Loaded notices dated 2026-11-05 to 2026-11-19; 0 notices not yet loaded. Covers loaded notices only, not a complete historical approval database.
Listed by the company name as recorded in the source, without merging affiliated entities.
This page summarizes loaded records only. Parent companies, subsidiaries, former names and aliases are not merged. Counts from different sources must not be added together. No loaded record does not establish the absence of a filing or registration. Check original records where coverage is incomplete, an update has failed, or a source lies outside the loaded scope.
Fact dates are approval dates, acceptance dates, trial first-publication dates, or the date an application stopped being listed as under review. Publication dates and dates added to this site are listed separately. Historical records with earlier dates are not current-period new events. Exit records cover currently inactive applications whose delisting date is known, not a full review history.
Drugs with a verified official English name use that name only. Other drug names retain the Chinese source name marked No verified English name; names with a Chinese public page link to that page. Company labels use verified official names, Latin source names, then fixed-rule transliterations marked romanized; Chinese company names are not displayed. Marked unverified drug names and original statutory reference numbers may appear in Chinese.
Legal reference identifiers are retained verbatim. Company labels use official English entries where available, or a visibly marked fixed romanization. Unverified drug names retain the Chinese source name with a No verified English name marker. Other Chinese free text is not displayed; use the source links or source-name columns in CSV exports.